| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |